Sun Pharmaceutical Industries Ltd.

Sun House, Plot No. 201 6/1,

Western Express Highway, Goregaon (E),
Mumbai - 400 063, Maharashtra, INDIA. ~
Tel. : (91-22) 43244324
Fax: (91-22) 4324 4843
www:sunpharma.com
SUN
PHARMA
CIN: L24230GJ1993PLC019050

February 16, 2017

National Stock Exchange of India Ltd, BSE Ltd,

Exchange Plaza, 5th Floor, Market Operations Dept.
Plot No. C/l, G Block, P. J. Towers, Dalal Street,
Bandra Kurla Complex, Mumbai - 400 OOL
Bandra (East), Mumbai - 400 05l. BSE Code - 524715
NSE Code - SUNPHARMA

Sub: Clarification !Information on news item

Dear Sirs,

With reference to your letter and email dated February 16, 2017 referring to recent news item appeared
,on CNBC TV18 dated February 16, 2017 captioned "UK Regulator approves Sun Pharma's Generic drug
of Tobramycin", we hereby submit our response as follows:

There is no information under regulation 30 that has not been announced to the Exchanges which could
explain the movement in the trading.

Please further note that the approval for the aforesaid product, received by one of our wholly owned
subsidiary companies, is not from UK regulator but from European Medicines Agency. However this is
not a material development for the Company. Sun Pharma and its subsidiaries continue to file multiple
products across multiple countries globally on an on-going basis. As and when there are material
developments, we will make the required disclosures.

Kindly let us know in case you require any further clarification.

Yours faithfully,

For Sun Pharmaceutical Industries Limited,

A. f
~shok iB'huta
11,(,---
Compliance Officer